Key result
OCT identifies stent overlap neoatheroma driving very-very late stent thrombosis >9 years post-DES.
Why the study?
Very-very late stent thrombosis occurring more than 5 years after drug-eluting stent implantation is extremely rare and had not been described with later-generation stents.
Case Report (n=1)
No
Very-very late stent thrombosis can occur nearly a decade after second-generation DES implantation, particularly at stent overlap zones prone to neo-atheroma formation, highlighting the utility of OCT in understanding stent failure mechanisms.
Alerts clinicians to very late thrombosis risk beyond 9 years in second-generation DES; hypothesis-generating for OCT surveillance of overlap neo-atheroma.
BACKGROUND: Very-very late stent thrombosis (VVLST) occurring more than 5 years after implantation of drug-eluting stent (DES) is extremely rare, being restricted to few case reports. Mainly described with first-generation stents, this life-threatening complication has not been described with later-generation stents. We describe the first case of VVLST occurring 3309 days (>9 years) after implantation of second-generation DES. CASE SUMMARY: A 62-year-old man presented with the acute coronary syndrome. He has a history of percutaneous coronary intervention (PCI) to the right coronary artery using the three second-generation DES more than 9 years ago. Coronary angiogram revealed in-stent restenosis (ISR) with doubtful angiographic thrombus. Optical coherence tomography (OCT) confirmed the diagnosis of stent thrombosis (STh) localized to the stent overlap zone with underlying ISR. Patient underwent OCT-guided PCI with DES implantation and was discharged on dual antiplatelet therapy including ticagrelor. He is doing well on follow-up at 6 months. DISCUSSION: Stent thrombosis can occur in second-generation stents nearly a decade after implant. Stent overlap segment is more prone to neo-atheroma formation and vulnerable plaque leading to STh. In addition to confirming the diagnosis, OCT provides exciting insights into the underlying mechanism. This has implications for long-term antiplatelet therapy in patients implanted with multiple stents.
No takes yet. Share an insight, caveat, or question.
Otaal et al. (2021) conducted a case report in Very-very late stent thrombosis (n=1). Second-generation drug-eluting stent was evaluated. Very-very late stent thrombosis can occur in second-generation drug-eluting stents more than 9 years after implantation, with OCT revealing stent overlap segments as prone to lipid-rich neo-atheroma and plaque rupture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: